Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer

Clinical trial NCT05817214 · RECRUITING

Trial details

NCT number: NCT05817214
Sponsor: Zhongnan Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2023-02-16
Primary completion: 2025-11-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.